Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain
Frontiers in Cardiovascular Medicine · 28.02.2024 · 11
DOI: 10.3389/fcvm.2024.1324537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 28.02.2024. Verfasst von Icíar Martínez López und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Service and Molecular Diagnostics and Clinical Genetics Unit, Hospital Universitario Son Espases, Balearic Islands, Palma de Mallorca, Spain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Atherosclerotic cardiovascular disease (ASCVD) is one of the main causes of morbidity and mortality in developed countries and entails high resources use and costs for health systems. The risk of suffering future cardiovascular (CV) events and the consequent resources use is higher in those patients who have already had a previous cardiovascular event. The objective of the study was to determine the average annual cost of patients with a new or recurrent atherosclerotic CV event during the 2 years after the event. Methodology Retrospective observational study of electronic medical records of patients from the BIG-PAC® database (7 integrated health areas of 7 Autonomous Communities; n = 1.8 million). Patients with a new or recurrent episode of ASCVD (angina, acute myocardial infarction, transient ischemic attack, stroke, or peripheral arterial disease) between 1-Jan-2017 and 31-Dec-2018 were included. The resources use within two years of the diagnosis was estimated in order to estimate the average cost of patient follow-up.
Results
A total of 26,976 patients with an ASCVD episode were identified during the recruitment period; Out of them, 6,798 had a recurrent event during the follow-up period and 2,414 died. The average costs per patient were €11,171 during the first year and €9,944 during the second year.
Discussion
Patients with ASCVD represent a significant economic burden for the health system and for society. Despite the perception that drug costs in the follow-up of chronic patients imply a high percentage of the costs, these accounted for only one tenth of the total amount. Implementing preventive programs and increasing the control of cardiovascular risk factors may have a significant social and health impact by helping to reduce mortality and costs for the Spanish National Health System. The costs derived from pharmacological treatments were obtained from the NHS pricing nomenclator database ( https://www.sanidad.gob.es/profesionales/nomenclator.do ).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Service and Molecular Diagnostics and Clinical Genetics Unit, Hospital Universitario Son Espases, Balearic Islands, Palma de Mallorca, Spain.
- Internal Medicine Service, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Madrid, Spain.
- Cardiology Service, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain.
- Department of Medicine, Universidad de las Islas Baleares, Palma de Mallorca, Spain.
- CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN CB 12/03/30038), Instituto de Salud Carlos III, Madrid, Spain.
- Family Medicine Service, Health Center of Isla de Oza, Madrid, Spain.
Zitieren
APA
Martínez López, I., Gómez Cerezo, J. F., Gámez, J. M., Egocheaga Cabello, I., Castellanos, M., Campuzano Ruiz, R., Barrios, V., Pallarés-Carratalá, V., Rodríguez, J. M., Morant Talamante, N., Parrondo, J., & Mostaza, J. M. (2024). Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1324537
Vancouver
Martínez López I, Gómez Cerezo JF, Gámez JM, Egocheaga Cabello I, Castellanos M, Campuzano Ruiz R, et al. Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1324537
BibTeX
@article{MartnezLpez2024,
author = {Martínez López, Icíar and Gómez Cerezo, Jorge Francisco and Gámez, José M and Egocheaga Cabello, Isabel and Castellanos, Mar and Campuzano Ruiz, Raquel and Barrios, Vivencio and Pallarés-Carratalá, Vicente and Rodríguez, José Manuel and Morant Talamante, Nuria and Parrondo, Javier and Mostaza, José María},
title = {Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1324537}
}
EUVIMED